SCHEMBL3271341

SCHEMBL3271341

CCCOCC1CC[N]C1=O

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3269720 0.85
SCHEMBL3271305 0.71 SMN1; SMN2 (0.33) SMN1; SMN2
SCHEMBL27506837 0.69 CA1 (0.36) SMN1; SMN2ALDH1A1
SCHEMBL1134441 0.68 CA1 (0.41) SMN1; SMN2ALDH1A1
SCHEMBL14651382 0.68 SMN1; SMN2 (0.35) SMN1; SMN2
SCHEMBL3266018 0.64 SMN1; SMN2 (0.32) SMN1; SMN2ALDH1A1TDP1
SCHEMBL1134498 0.64 SMN1; SMN2 (0.34) SMN1; SMN2ALDH1A1TDP1
SCHEMBL3267149 0.63 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1TDP1
SCHEMBL16108499 0.62 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1TDP1
SCHEMBL127998 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517881-B1 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2010-06-02 EP disclosed
US-7414064-B2 4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives SYNGENTA CROP PROTECTION, INC. (US) 2008-08-19 US disclosed
US-20070142445-A1 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives SYNGENTA CROP PROTECTION, INC. (US) 2007-06-21 US disclosed
US-7192965-B2 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives SYNGENTA CROP PROTECTION, INC. (US) 2007-03-20 US disclosed
US-20050245583-A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives SYNGENTA CROP PROTECTION, INC. 2005-11-03 US disclosed
EP-1517881-A1 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES Syngenta Participations AG (CH) 2005-03-30 EP disclosed
WO-2004002943-A1 4-(3,3-DIHALO-ALLYLOXY)PHENOXY ALKYL DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2004-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245583-A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives DDT, RER1, SCN7A SMN1; SMN2 689/4885ALDH1A1 3383/4885TDP1 4240/4885
US-20070142445-A1 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives DDT, RER1, SCN7A SMN1; SMN2 689/4885ALDH1A1 3383/4885TDP1 4240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.